MoonLake Immunotherapeutics - 54 Year Dividend History | MLTX
Historical dividend payout and yield for MoonLake Immunotherapeutics (MLTX) since 1971. The current TTM dividend payout for MoonLake Immunotherapeutics (MLTX) as of January 17, 2025 is $0.00. The current dividend yield for MoonLake Immunotherapeutics as of January 17, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.800B |
$0.000B |
|
MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
